Coldstream Laboratories Names Head of Formulation Development - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Coldstream Laboratories Names Head of Formulation Development



Untitled Document

Coldstream Laboratories, a provider of sterile drug product development and manufacturing services, has named Adrian Raiche, PhD, as director of formulation development. In this position, Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization, and scale-up activities for manufacturing in the company’s sterile manufacturing facility.

Raiche has experience in several aspects of pharmaceutical development, including lyophilization and potent compound handling.  Most recently, he served as manager of pharmaceutical development at Summit Biosciences contributing to formulation, analytical, and process development of nasal-spray products.  Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals, and Bausch and Lomb. 

Source: Coldstream Laboratories

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here